To mark World Cancer Day, Cancer Research UK are taking a look at how research that is happening in partnership with other countries is making the future brighter for cancer patients across the globe.
The Add-Aspirin trial, running in the UK, and soon to be India, is looking at whether aspirin can prevent cancer from coming back.
"Every day we see patients who are unable to afford the costs of expensive cancer therapy - they would benefit greatly from in inexpensive form of cancer treatment like aspirin," says Dr Conjeevaram Pramesh, from the Tata Memorial Hospital, Mumbai, leading the Add-Aspirin trial in India. "There is immense potential for a simple, cost-effective treatment like aspirin to help people with Cancer in India and other resource-poor countries."
But importantly, people should not start taking aspirin without first speaking to their doctor, as aspirin isn't suitable for everyone and it can have serious side effects. Please speak to your oncologist or research nurse if you would like to join the Add-Aspirin trial.
Read more here.
Contact Details
If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.
For healthcare professionals
Please log into the members area for Add-Aspirin contact details.
Register Interest
For healthcare professionals
If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk
From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK